Amiodarone-induced thyrotoxicosis

被引：6

作者：

Schubert, Louis ^{[1
]}

Bricaire, Leopoldine ^{[1
]}

Groussin, Lionel ^{[1
,2
,3
]}

机构：

[1] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France

[2] Univ Paris, F-75014 Paris, France

[3] Inst Cochin, Inserm Unite 1016, CNRS UMR 8104, F-75014 Paris, France

来源：

ANNALES D ENDOCRINOLOGIE | 2021年 / 82卷 / 3-4期

关键词：

Amiodarone; Thyrotoxicosis; Hyperthyroidism; ASSOCIATION; GUIDELINES; MANAGEMENT; TYPE-2; THYROIDECTOMY; CONTINUATION; THERAPY;

D O I：

10.1016/j.ando.2020.04.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018. (C) 2020 Elsevier Masson SAS. All rights reserved.

引用

页码：163 / 166

页数：4

共 50 条

[31] Amiodarone-induced Thyrotoxicosis with Cardiopulmonary Arrest
Inoue, Kosuke
Saito, Jun
Kondo, Tetsuo
Miki, Kaoru
Sugisawa, Chiho
Tsurutani, Yuya
Hasegawa, Naoki
Kowase, Shinya
Kakuta, Yukio
Omura, Masao
Nishikawa, Tetsuo
INTERNAL MEDICINE, 2018, 57 (01) : 59 - 63
[32] Approach to the Patient with Amiodarone-Induced Thyrotoxicosis
Bogazzi, Fausto
Bartalena, Luigi
Martino, Enio
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (06) : 2529 - 2535
[33] Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
Laurent Uzan
Laurence Guignat
Christophe Meune
Stéphane Mouly
Simon Weber
Xavier Bertagna
Jérôme Bertherat
Pierre Thomopoulos
Denis Duboc
Drug Safety, 2006, 29 : 231 - 236
[34] Hyperthyroidism in an elderly patient - Amiodarone-induced thyrotoxicosis.
Findlay, PF
Seymour, DG
POSTGRADUATE MEDICAL JOURNAL, 2000, 76 (893) : 173 - 175
[35] Amiodarone-induced thyrotoxicosis in a case of Eisenmenger's syndrome
Czarnywojtek, Agata
Wolinski, Kosma
Wasko, Ryszard
Florek, Ewa
Zgorzalewicz-Stachowiak, Malgorzata
Fichna, Marta
Greberska, Weronika
Guzik, Przemyslaw
Lodyga, Martha
Kwiecinska, Barbara
Ruchala, Marek
NEUROENDOCRINOLOGY LETTERS, 2013, 34 (08) : 767 - 772
[36] Thyroid arterial embolization in a patient with congenital heart disease and refractory amiodarone-induced thyrotoxicosis
Bouca, Bruno
Martins, Ana Claudia
Bogalho, Paula
Sousa, Lidia
Bilhim, Tiago
Gomes, Filipe Veloso
Coimbra, Elia
Agapito, Ana
Silva-Nunes, Jose
EUROPEAN THYROID JOURNAL, 2022, 11 (01)
[37] Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT)
Czarnywojtek, Agata
Czepczynski, Rafal
Ruchala, Marek
Wasko, Ryszard
Zgorzalewicz-Stachowiak, Magorzata
Szczepanek, Ewelina
Zamyslowska, Hanna
Bartkowiak, Zuzanna
Florek, Ewa
Sowinski, Jerzy
NEUROENDOCRINOLOGY LETTERS, 2009, 30 (02) : 209 - 214
[38] Amiodarone-induced Thyrotoxicosis in Children and Adolescents is a Possible Outcome in Patients with Low Iodine Intake
Hacihamdioglu, Buelent
Berberoglu, Merih
Siklar, Zeynep
Erdeve, Senay Savas
Ocal, Goenuel
Tutar, Ercan
Atalay, Semra
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2010, 23 (04) : 363 - 368
[39] Amiodarone-induced thyrotoxicosis in a pediatric patient: A rare and demanding clinical case
Oliveira, Sofia
Marques, Bernardo
Laranjo, Sergio
Lopes, Lurdes
PEDIATRIC REPORTS, 2019, 11 (03) : 56 - 58
[40] RETROSPECTIVE EVALUATION OF DIAGNOSTIC METHODS AND TREATMENT OPTIONS IN AMIODARONE-INDUCED THYROTOXICOSIS
Catikkas, Nezahat Muge
Dogru Hacisahinogullari, Hulya
Gul, Nurdan
Selcukbiricik, Ozlem Soyluk
Aral, Ferihan
Tanakol, Refik
Kubat Uzum, Ayse
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2023, 86 (03): : 227 - 234

← 1 2 3 4 5 →